The Valley Desk

ArticleJCO precision oncologyPublished

Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
JCO precision oncology
Published
Subject terms
Humans; Cell Cycle Proteins; Nuclear Proteins; Transcription Factors; Antineoplastic Agents; Bromodomain Containing Proteins
PubMed ID
37384867
PubMed Central ID
PMC10581614
Added to directory
Source checked

Report a correction or request removal